Загрузка...
Regulation of platelet count by erythropoiesis-stimulating agents – iron axis in hemodialysis patients
Higher doses of erythropoiesis-stimulating agents (ESAs) contribute to atherothrombotic cardiovascular disease in hemodialysis (HD) patients. Thrombocytosis is associated with increased mortality in ESA-treated HD patients. We investigated variables affecting platelet count and its variability (plat...
Сохранить в:
| Опубликовано в: : | Int J Nephrol Renovasc Dis |
|---|---|
| Главные авторы: | , , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Dove Medical Press
2016
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4822794/ https://ncbi.nlm.nih.gov/pubmed/27099526 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/IJNRD.S98196 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|